July 27, 2012 Approval of new drugs slowing Fewer new prescription drugs will get approved in the U.S. this year than the 30 approved in 2011, a ratings agency forecasts, add
July 10, 2012 Tucson tech: Tucson’s C-Path drug institute looks to boost its future funding Tucson’s Critical Path Institute recently got some good news – and some noteworthy recognition – when the U.S. S
May 16, 2012 Stakeholders Share Data to Design Better Trials for Neurodegenerative Diseases The Coalition Against Major Diseases is pooling clinical data to build disease and drug models.
May 2, 2012 Renewed Focus on Tuberculosis Holds Promise for New Treatments FDA approved rifampin for the treatment of tuberculosis (TB) in 1971, the same year Intel Corporation invented the first microproc
April 25, 2012 Tucson institute plays critical cancer role Re: the April 19 article “Vast study advances breast cancer fight.”
April 24, 2012 ACRO Testifies Before FDA on Clinical Trial Modernization WASHINGTON–(BUSINESS WIRE)– The Association of Clinical Research Organizations (ACRO) today provided the FDA with a nu
April 21, 2012 C-Path Initiative’s Work on Personalized Medicine Starts to Get Results The Critical path Institute (C-Path), the US Food and Drug Administration (FDA)-supported public-private initiative working to adv
April 18, 2012 C-Path Looks to Speed Gene Based Therapies Your doctor may soon – perhaps in a year – be able to order up a test to map out your entire genome, or genetic bluepr